A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes.

J Ayurveda Integr Med · 2023 · PMC10587713 · PMID 37857033

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In our study, all the patients had IDRS scores above 60, however following treatment with Nisha-Amalaki capsules, a fall in the IDRS score was noted in these patients at 6 months which was highly significant as compared to the scores noted in patients who received Placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.